|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | The University of Texas, Galveston |
|---|---|
| Information provided by (Responsible Party): | The University of Texas, Galveston |
| ClinicalTrials.gov Identifier: | NCT00675922 |
Purpose
Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).
| Condition | Intervention | Phase |
|---|---|---|
|
Burn |
Drug: Sulfamylon Solution 5% Drug: Dakins 0.025% solution Drug: Cerium solution Drug: Silver Nitrate |
Phase II Phase III |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds |
| Enrollment: | 98 |
| Study Start Date: | July 1995 |
| Study Completion Date: | May 2008 |
| Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Application of Sulfamylon 5% Solution
|
Drug: Sulfamylon Solution 5%
Application of Sulfamylon Solution to burn wound daily
Other Name: Sulfamylon
|
|
Experimental: 2
Application of Dakins 0.025% Solution
|
Drug: Dakins 0.025% solution
Application of Dakins solution to burn wound daily.
Other Name: Sodium hypochloride
|
|
Experimental: 3
Application of Cerium Solution
|
Drug: Cerium solution
cerium solution applied to burn wounds daily.
Other Name: cerium
|
|
Experimental: 4
Application of Silver Nitrate Solution
|
Drug: Silver Nitrate
Silver Nitrate solution applied to burn wounds daily
|
Eligibility| Ages Eligible for Study: | up to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Texas | |
| University of Texas Medical Branch | |
| Galveston, Texas, United States, 77555 | |
| Principal Investigator: | David N Herndon, MD | University of Texas |
More Information
| Responsible Party: | The University of Texas, Galveston |
| ClinicalTrials.gov Identifier: | NCT00675922 History of Changes |
| Other Study ID Numbers: | 95-096 |
| Study First Received: | December 26, 2007 |
| Last Updated: | December 6, 2011 |
| Health Authority: | United States: Institutional Review Board |
|
Burn Wounds Wound infection Topical antimicrobials |
Cerium Dakins Sulfamylon Soaks Silver Nitrate |
|
Burns Wounds and Injuries Silver Nitrate Mafenide |
Anti-Infective Agents Anti-Infective Agents, Local Therapeutic Uses Pharmacologic Actions |